Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9
Claudia Langenberg(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Christina M. Lill(University of Münster), Lars Bertram(Universitat Internacional de Catalunya), Jackie F. Price(University of Edinburgh), Kristina Norman(University of Potsdam), Karin Willeit(Innsbruck Medical University), Amand F. Schmidt(University of Cambridge), Stela McLachlan(University of Edinburgh), Catherine Welch(University College London), Elisabeth Steinhagen‐Thiessen(Charité - Universitätsmedizin Berlin), Richard Morris(University of Nottingham), Zammy Fairhurst-Hunter(Centre for Human Genetics), Elina Hyppönen(South Australian Health and Medical Research Institute), Bernardo Lessa Horta(Universidade Federal de Pelotas), Mika Kivimäki(University of Helsinki), Juri Demuth, Adelaida Sánchez-Gálvez(University College London), Dan Mason(Bradford Teaching Hospitals NHS Foundation Trust), Carlotta Sacerdote(Cancer Prevention Institute of California), David Preiss(Medical Research Council), N. Charlotte Onland‐Moret(St. Elizabeth's Hospital), Stefan Kiechl(Innsbruck Medical University), Pedro Marques‐Vidal(University Hospital of Lausanne), Dennis Valentine(Health Data Research UK), Kees Hovingh(Amsterdam UMC Location University of Amsterdam), Yoav Ben‐Shlomo(University of Bristol), Ghazaleh Fatemifar(University of London), Yvonne T. van der Schouw(University Medical Center Utrecht), Simonetta Guarrera(Italian institute for Genomic Medicine), Daniel I. Swerdlow(Silence Therapeutics (United Kingdom)), Andrew Nicolaides(Imperial College London), Andrie G. Panayiotou(Cyprus University of Technology), Peter H. Whincup(St George's, University of London), Spiros Denaxas(University College London), Ilja Demuth(Charité - Universitätsmedizin Berlin), Max Moldovan(University of South Australia), John Wright(Bradford Teaching Hospitals NHS Foundation Trust), Chris Finan(British Heart Foundation), Fernando Pires Hartwig(Universidade Federal de Pelotas), Giuseppe Matullo(Italian institute for Genomic Medicine), Rupert Faraway(King's College London), Stefan Coassin(Innsbruck Medical University), Giovanni Fiorito(Italian institute for Genomic Medicine), Nicholas J. Wareham(University of Cambridge), Johann Willeit(Innsbruck Medical University), Christine Power(Great Ormond Street Hospital), Michael V. Holmes(University of Bristol), Goya Wanamethee(University College London), Erik Van Iperen(Amsterdam UMC Location University of Amsterdam)
Cited by 47
Related Papers
The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis
|American Journal of Psychiatry|2007|5.3k
Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals
|Nature Genetics|2018|2.9k
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
|The Lancet|2016|2.8k
TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods
|BMJ|2024|2.8k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k